Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CANAKINUMAB Cause Photosensitivity reaction? 103 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Photosensitivity reaction have been filed in association with CANAKINUMAB (Ilaris). This represents 1.0% of all adverse event reports for CANAKINUMAB.

103
Reports of Photosensitivity reaction with CANAKINUMAB
1.0%
of all CANAKINUMAB reports
56
Deaths
85
Hospitalizations

How Dangerous Is Photosensitivity reaction From CANAKINUMAB?

Of the 103 reports, 56 (54.4%) resulted in death, 85 (82.5%) required hospitalization, and 93 (90.3%) were considered life-threatening.

Is Photosensitivity reaction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANAKINUMAB. However, 103 reports have been filed with the FAERS database.

What Other Side Effects Does CANAKINUMAB Cause?

Pyrexia (1,327) Inappropriate schedule of drug administration (1,238) Drug ineffective (1,078) Inappropriate schedule of product administration (944) Pain (858) Condition aggravated (771) Malaise (684) Off label use (557) Arthralgia (555) Rash (505)

What Other Drugs Cause Photosensitivity reaction?

PIRFENIDONE (686) ADALIMUMAB (653) METHOTREXATE (514) DUPILUMAB (440) VORICONAZOLE (413) ETANERCEPT (386) NIRAPARIB (365) VEMURAFENIB (321) HYDROXYCHLOROQUINE (271) CIPROFLOXACIN (269)

Which CANAKINUMAB Alternatives Have Lower Photosensitivity reaction Risk?

CANAKINUMAB vs CANDESARTAN CANAKINUMAB vs CANDESARTAN CILEXETIL CANAKINUMAB vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE CANAKINUMAB vs CANGRELOR CANAKINUMAB vs CANIS LUPUS FAMILIARIS SKIN

Related Pages

CANAKINUMAB Full Profile All Photosensitivity reaction Reports All Drugs Causing Photosensitivity reaction CANAKINUMAB Demographics